首页> 外文期刊>Toxicology in vitro: an international journal published in association with BIBRA >In vivo-in vitro comparison of acute respiratory tract toxicity using human 3D airway epithelial models and human A549 and murine 3T3 monolayer cell systems
【24h】

In vivo-in vitro comparison of acute respiratory tract toxicity using human 3D airway epithelial models and human A549 and murine 3T3 monolayer cell systems

机译:使用人3D气道上皮模型和人A549和鼠3T3单层细胞系统的体内呼吸道毒性比较急性呼吸道毒性的体外比较

获取原文
获取原文并翻译 | 示例
       

摘要

The usefulness of in vitro systems to predict acute inhalation toxicity was investigated. Nineteen substances were tested in three-dimensional human airway epithelial models, EpiAirway? and MucilAir?, and in A549 and 3T3 monolayer cell cultures. IC50 values were compared to rat four-hour LC50 values classified according to EPA and GHS hazard categories. Best results were achieved with a prediction model distinguishing toxic from non-toxic substances, with satisfactory specificities and sensitivities. Using a self-made four-level prediction model to classify substances into four in vitro hazard categories, in vivo-in vitro concordance was mediocre, but could be improved by excluding substances causing pulmonary edema and emphysema in vivo. None of the test systems was outstanding, and there was no evidence that tissue or monolayer systems using respiratory tract cells provide an added value. However, the test systems only reflected bronchiole epithelia and alveolar cells and investigated cytotoxicity. Effects occurring in other cells by other mechanisms could not be recognised. Further work should optimise test protocols and expand the set of substances tested to define applicability domains. In vivo respiratory toxicity data for in vitro comparisons should distinguish different modes of action, and their relevance for human health effects should be ensured.
机译:研究了体外系统预测急性吸入毒性的有用性。在epiairway中,在三维人气道上皮模型中测试了19种物质?和粘液?,在A549和3T3单层细胞培养物中。将IC50值与大鼠4小时LC50值进行比较,根据EPA和GHS危险类别进行分类。通过从无毒物质的预测模型实现最佳结果,具有令人满意的特异性和敏感性。使用自制的四级预测模型将物质分类为四种体外危险类别,体内体外的一致性是平庸的,但可以通过排除导致肺水肿和体内肺气肿的物质来改善。没有一个测试系统出现突出,并且没有证据表明使用呼吸道细胞的组织或单层系统提供了附加值。然而,测试系统仅反射支气管上皮和肺泡细胞并研究了细胞毒性。无法识别其他机制在其他电池中发生的效果。进一步的工作应优化测试协议,并展开测试以定义适用性域的一组物质。在体外比较的体内呼吸系统毒性数据中应区分不同的行动模式,应确保其对人体健康影响的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号